-
-
-
-
-
-
-
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026, at 8:00 a.m. ET
-
-
-
-
-
-
-
ANI Pharmaceuticals (ANIP) PT Raised to $114 at Guggenheim
-
-
-
-
-
-
-
ANI Pharmaceuticals (ANIP) PT Raised to $82 at Leerink Partners
-
-
-
-
-
-
-
ANI Pharma (ANIP) Tops Q3 EPS by 26c ; Offers Guidance
-
-
-
-
-
-
-
ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner
-
-
-
-
-
-
-
ANI Pharma (ANIP) Tops Q3 EPS by 43c
-
-
-
-
-
-
-
ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
-
1,208,881 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

